A CRISPR/Cas9 screening using co-culture experiments with melanoma cells and gp100-specific T cells identified the chromatin remodeling complex pBAF as an inducer of resistance to T cell killing by regulating chromatin accessibility on IFN-γ response targets (117). This evidence concerns the gene IFNG and melanoma.